(Total Views: 103)
Posted On: 01/15/2021 10:37:30 AM
Post# of 43997
Re: trooperstocks #23189
$CURR - There is huge revenue potential available from the company's new ED treatment oral thin film product line which has now been advanced via the recent FDA action that was reported. This is a product line that can be a game changer for shareholder value here.
CURE Pharmaceutical Receives FDA Approval for its IND Application for Erectile Dysfunction Product CUREfilm Blue™
https://www.curepharmaceutical.com/press-rele...sfunction/
The global erectile dysfunction drug market is projected to reach approximately USD$6.6 Billion by 2025, at a CAGR of 6.0% over the five-year forecasted period with sildenafil representing a majority of the market according to a report by QYR Research.
CURE Pharmaceutical Receives FDA Approval for its IND Application for Erectile Dysfunction Product CUREfilm Blue™
https://www.curepharmaceutical.com/press-rele...sfunction/
The global erectile dysfunction drug market is projected to reach approximately USD$6.6 Billion by 2025, at a CAGR of 6.0% over the five-year forecasted period with sildenafil representing a majority of the market according to a report by QYR Research.
(0)
(0)
